The 2022 Quest for a Cure Gala raised over $230,000 for research!

The 2022 gala marked ten years of significantly impacting the lives of thousands of Castleman disease patients around the world. Ten years of relentless research to better understand the cause of Castleman disease and how to treat it effectively. And ten years of successfully turning our hope for cures into action.

The gala joined together patients, loved ones, and community members to raise awareness and funds for Castleman disease research. We had an exciting program with remarks from the CDCN’s co-founder, Dr. David Fajgenbaum, physician-scientist at the University of Pennsylvania, and the author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action. The CDCN would like to thank our headline sponsor, EUSA Pharma.

About the CDCN

The CDCN’s innovative approach to transforming Castleman disease research over the last eight years has resulted in the first diagnostic criteria for Castleman disease, first treatment guidelines, first new drug target in 25 years, and the first clinical trial for patients with treatment-refractory Castleman disease. This work has been profiled on Good Morning America, New York Times, CNN, Philadelphia Inquirer, NPR Fresh Air, and the Lifetime TV Network. The CDCN has also partnered with the Chan Zuckerberg Initiative to expand the CDCN’s approach to research to advance cures for other rare diseases. 

More Information

• Prefer to send a check by mail? Make out to “CDCN” (Castleman Disease Collaborative Network), notate “Quest for A Cure”, and send to Castleman Disease Collaborative Network, PO Box 3614 Paso Robles, CA 93447.
• Questions? Email quest@castlemannetwork.org or call (610) 304-0696.
• CDCN is a 501 (c) (3) nonprofit organization. All donations are tax-deductible in accordance with IRS regulations.